Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

17 trials with published results (7%)

Research Maturity

87 completed trials (37% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.3%

10 terminated out of 235 trials

Success Rate

89.7%

+3.1% vs benchmark

Late-Stage Pipeline

15%

36 trials in Phase 3/4

Results Transparency

20%

17 of 87 completed with results

Key Signals

17 with results90% success

Data Visualizations

Phase Distribution

144Total
Not Applicable (81)
P 1 (6)
P 2 (21)
P 3 (13)
P 4 (23)

Trial Status

Completed87
Unknown65
Recruiting38
Not Yet Recruiting24
Terminated10
Active Not Recruiting6

Trial Success Rate

89.7%

Benchmark: 86.6%

Based on 87 completed trials

Clinical Trials (235)

Showing 20 of 20 trials
NCT07754617Phase 2Not Yet Recruiting

Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis: an RCT

NCT05794555Phase 3Completed

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis

NCT07140120Active Not Recruiting

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis - Supplementary Study

NCT05711316Not ApplicableActive Not RecruitingPrimary

The BD Liverty™ TIPS Stent Graft Study

NCT07703540Completed

Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient Measurement

NCT07699354Not ApplicableNot Yet Recruiting

Cyanoacrylate Glue Versus Absorbable Gelatin Sponge for Gastric Varices

NCT07554183Not ApplicableNot Yet Recruiting

4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis

NCT06099015Recruiting

Cera™ Vascular Plug System Post-Market Clinical Follow-Up

NCT07598669Recruiting

Austrian PBC Registry

NCT07585786Not Yet Recruiting

Effect of LSD on Renal Function in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)

NCT07358663Recruiting

Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices

NCT07588334Not Yet Recruiting

Effect of LSD on Lipid Profiles in Cirrhosis Patients With Portal Hypertension Bleeding (2-Year Follow-Up)

NCT07587671Not ApplicableNot Yet Recruiting

Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis

NCT07571876Not Yet Recruiting

Ultrasound Prediction of Esophageal Variceal Bleeding Risk

NCT05027425Phase 2Terminated

Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant

NCT05872698Phase 4Active Not Recruiting

Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.

NCT06576934Not ApplicableRecruiting

Early TIPS in Patients With Liver Cirrhosis and Ascites

NCT05782556Recruiting

Freiburg TIPS Registry

NCT07304466Not ApplicableRecruiting

Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation

NCT07439939Recruiting

Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Placement

Scroll to load more

Research Network

Activity Timeline